Vendor profile Research · US · —

Shanghai Wibson Biotechnology WBS

B+
Composite 7.7 / 10

Last updated 2026-10-05. Composite is computed from the live database; missing sub-scores redistribute weight across the others.

Lab quality
6.6
Good
Sentiment
—
—
COA
—
Limited
Reliability
—
— tenure
Pricing
10.0
Verified

Peptide breakdown

PeptideScoreLab qualityTestsPurity Qty var.$/mg verifiedLast testRanking
GHK-Cu
8.8B+
8.5 4 — — — — view
Tirzepatide
8.8B+
8.5 12 — — — — view
Retatrutide
8.4B+
8.0 21 — — — — view
Ipamorelin
7.6B+
7.0 4 — — — — view
BPC-157
6.3C
5.4 6 — — — — view
Tesamorelin
6.1C
5.1 7 — — — — view
TB-500
3.7D
3.7 3 — — — — view
PT-141
—
— 0 — — — — view
CJC-1295
—
— 0 — — — — view
Thymosin Alpha 1
—
— 0 — — — — view

COA transparency

  • ○ Publishes per-batch COAs (not just one COA for everyone) (pending)
  • ○ Both HPLC and mass spec shown (pending)
  • ○ Endotoxin or sterility data shown (pending)
  • ○ At least one COA independently cross-checked (pending)
  • ○ Most recent COA within 90 days (pending)
All vendor grades, side-by-side
Compare Shanghai Wibson Biotechnology WBS against every other vendor in the grade hub →
Top-5 ranked vendors per peptide, plus the highest-rated vendors overall. Daily refresh.